These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29101669)

  • 21. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.
    Gumus Balikcioglu P; Balikcioglu M; Muehlbauer MJ; Purnell JQ; Broadhurst D; Freemark M; Haqq AM
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3822-31. PubMed ID: 26259133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    J Child Psychol Psychiatry; 2017 Jan; 58(1):64-74. PubMed ID: 27481444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome.
    Mele C; Grugni G; Mai S; Vietti R; Aimaretti G; Scacchi M; Marzullo P
    Sci Rep; 2017 Jun; 7(1):3186. PubMed ID: 28600576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
    Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function.
    van Mil EG; Westerterp KR; Gerver WJ; Van Marken Lichtenbelt WD; Kester AD; Saris WH
    J Pediatr; 2001 Nov; 139(5):708-14. PubMed ID: 11713451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.
    Irizarry KA; Bain J; Butler MG; Ilkayeva O; Muehlbauer M; Haqq AM; Freemark M
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):797-805. PubMed ID: 25736874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Morabito F
    J Endocrinol Invest; 2001 May; 24(5):340-8. PubMed ID: 11407654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher plasma orexin A levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls.
    Manzardo AM; Johnson L; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Aug; 170(8):2097-102. PubMed ID: 27214028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher plasma orexin a levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls.
    Manzardo AM; Johnson L; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Sep; 170(9):2328-33. PubMed ID: 27518917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome.
    Brunetti G; Grugni G; Piacente L; Delvecchio M; Ventura A; Giordano P; Grano M; D'Amato G; Laforgia D; Crinò A; Faienza MF
    Calcif Tissue Int; 2018 Jun; 102(6):635-643. PubMed ID: 29353451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
    Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
    Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obestatin and adropin in Prader-Willi syndrome and nonsyndromic obesity: Associations with weight, BMI-z, and HOMA-IR.
    Orsso CE; Butler AA; Muehlbauer MJ; Cui HN; Rubin DA; Pakseresht M; Butler MG; Prado CM; Freemark M; Haqq AM
    Pediatr Obes; 2019 May; 14(5):e12493. PubMed ID: 30589518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
    Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
    Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.